HomeCompareBMY vs ISRG

BMY vs ISRG: Dividend Comparison 2026

BMY yields 4.00% · ISRG yields 0.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMY wins by $7.8K in total portfolio value
10 years
BMY
BMY
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full BMY calculator →
ISRG
ISRG
● Live price
0.44%
Share price
$452.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$45.46
Full ISRG calculator →

Portfolio growth — BMY vs ISRG

📍 BMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMYISRG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMY + ISRG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMY pays
ISRG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMY
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
ISRG
Annual income on $10K today (after 15% tax)
$37.55/yr
After 10yr DRIP, annual income (after tax)
$38.64/yr
At 15% tax rate, BMY beats the other by $725.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMY + ISRG for your $10,000?

BMY: 50%ISRG: 50%
100% ISRG50/50100% BMY
Portfolio after 10yr
$24.2K
Annual income
$472.33/yr
Blended yield
1.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ISRG right now

BMY
Analyst Ratings
19
Buy
20
Hold
2
Sell
Consensus: Hold
Price Target
$62.73
+25.5% upside vs current
Range: $40.00 — $75.00
Altman Z
2.3
Piotroski
8/9
ISRG
Analyst Ratings
37
Buy
12
Hold
5
Sell
Consensus: Buy
Price Target
$638.75
+41.1% upside vs current
Range: $550.00 — $750.00
Altman Z
37.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMY buys
0
ISRG buys
0
No recent congressional trades found for BMY or ISRG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMYISRG
Forward yield4.00%0.44%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth5%0%
5-year div CAGR5%0%
Portfolio after 10y$28.0K$20.3K
Annual income after 10y$899.19$45.46
Total dividends collected$6.4K$449.00
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusHoldBuy
Analyst price target$62.73$638.75

Year-by-year: BMY vs ISRG ($10,000, DRIP)

YearBMY PortfolioBMY Income/yrISRG PortfolioISRG Income/yrGap
1← crossover$11,120$420.00$10,744$44.17+$376.00BMY
2$12,357$458.31$11,541$44.35+$816.00BMY
3$13,721$499.76$12,393$44.53+$1.3KBMY
4$15,227$544.58$13,305$44.69+$1.9KBMY
5$16,885$593.02$14,281$44.84+$2.6KBMY
6$18,713$645.34$15,326$44.98+$3.4KBMY
7$20,724$701.81$16,444$45.11+$4.3KBMY
8$22,938$762.73$17,640$45.23+$5.3KBMY
9$25,372$828.41$18,920$45.35+$6.5KBMY
10$28,047$899.19$20,290$45.46+$7.8KBMY

BMY vs ISRG: Complete Analysis 2026

BMYHealthcare

BMY is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in BMY shares.

Full BMY Calculator →

ISRGStock

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Full ISRG Calculator →
📬

Get this BMY vs ISRG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMY vs SCHDBMY vs JEPIBMY vs OBMY vs KOBMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.